Latest Industry Insights

Novo Nordisk’s Transformational Prevention Unit (TPU) integrates AI, omics, and genomics to predict obesity risk and tailor interventions. By focusing on personalized solutions, TPU aims to prevent obesity and reduce the incidence of related diseases

Explore the clinical impact of accurate vitamin D measurement, how the cobas® Mass Spec solution enhances diagnostic precision and the broader role of clinical mass spectrometry in advancing personalized healthcare.

Chromatography-free mass spectrometry boosts throughput, cuts costs and simplifies drug monitoring – learn how Bruker and RECIPE are leading the way.

In this interview, Technology Networks spoke with Kara Egan, CEO and co-founder of Teal Health, to learn more about how they are reshaping cervical cancer prevention.

Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.

James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.

Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, Ferrocalm^TM, and how its innovative strategy could reshape the future of gut health.

Technology Networks spoke to Jason Barker, ND, clinical lab educator at Vibrant Wellness, to explore why co-infections from tick bites are frequently underdiagnosed and to examine current and future testing protocols of tick-borne diseases.

In this interview, Technology Networks spoke with Dr. Francesco Dell’Accio and Dr. Suzanne Eldridge to explore the impact of osteoarthritis on patients, the goals of ReFleks and a novel approach to repairing osteochondral defects.

A new pan-European network will integrate long-read sequencing into clinical practice, improving diagnosis of rare diseases and cancers.